Cyrano Therapeutics Sensing Opportunity with Lead Therapeutic Targeting Post-Viral Smell Loss

Cyrano Therapeutics is a clinical-stage regenerative medicine company pioneering the development of treatments for smell loss.  In this installment of Bench2Bedside, President and CEO Rick Geoffrion discusses his company, development plans, and why he believes CYR-064 has the potential to transform the treatment of smell...